Jilin Jian Yisheng Pharmaceutical Co Ltd Class A 002566
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- ¥6.44
- Day Range
- ¥6.47–6.84
- 52-Week Range
- ¥5.20–10.21
- Bid/Ask
- ¥6.70 / ¥6.71
- Market Cap
- ¥2.22 Bil
- Volume/Avg
- 6.7 Mil / 3.0 Mil
Key Statistics
- Price/Earnings (Normalized)
- 37.41
- Price/Sales
- 3.03
- Dividend Yield (Trailing)
- 2.24%
- Dividend Yield (Forward)
- 2.24%
- Total Yield
- 2.24%
Company Profile
Jilin Jian Yisheng Pharmaceutical Co Ltd is engaged in the research and development, production, and sales of pharmaceuticals, health foods, and cosmetics.
- Sector
- Healthcare
- Industry
- Biotechnology
- Stock Style Box
- Small Core
- Total Number of Employees
- 1,678
- Website
- http://www.yisheng-pharm.com
Comparables
Valuation
|
Metric
|
002566
|
603896
|
002693
|
|---|---|---|---|
Price/Earnings (Normalized) | 37.41 | 18.81 | — |
Price/Book Value | 1.00 | 2.05 | 13.63 |
Price/Sales | 3.03 | 5.76 | 32.92 |
Price/Cash Flow | 16.67 | 12.20 | 1,005.34 |
Price/Earnings
002566
603896
002693
Financial Strength
|
Metric
|
002566
|
603896
|
002693
|
|---|---|---|---|
Quick Ratio | 1.81 | 3.21 | 0.56 |
Current Ratio | 5.76 | 3.70 | 1.08 |
Interest Coverage | 6.74 | 16.62 | −9.96 |
Quick Ratio
002566
603896
002693
Profitability
|
Metric
|
002566
|
603896
|
002693
|
|---|---|---|---|
Return on Assets (Normalized) | 1.96% | 7.55% | −4.80% |
Return on Equity (Normalized) | 2.68% | 11.00% | −8.30% |
Return on Invested Capital (Normalized) | 2.11% | 7.10% | −4.45% |
Return on Assets
002566
603896
002693
Biotechnology Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Novo Nordisk AS ADR
NVO
| Swffscnmg | Fqfb | $531.4 Bil | |||
| Vertex Pharmaceuticals Inc
VRTX
| Gpsbgbjf | Rcfmm | $119.5 Bil | |||
| Regeneron Pharmaceuticals Inc
REGN
| Gmbxkcpxy | Nssbjy | $114.9 Bil | |||
| Alnylam Pharmaceuticals Inc
ALNY
| Jtbcmpvg | Fptkl | $35.3 Bil | |||
| argenx SE ADR
ARGX
| Klzxsgxy | Qmlp | $32.0 Bil | |||
| BioNTech SE ADR
BNTX
| Nzkdphkj | Rlk | $28.1 Bil | |||
| Moderna Inc
MRNA
| Ttzzwwf | Gfs | $25.3 Bil | |||
| United Therapeutics Corp
UTHR
| Bysjcwh | Lytvv | $16.0 Bil | |||
| Biomarin Pharmaceutical Inc
BMRN
| Kytvhdpj | Qhtxxl | $13.4 Bil | |||
| Incyte Corp
INCY
| Snbwlxh | Lzbgwt | $12.7 Bil |
United States